GlassScriptPhysician profile
Alejandro I Michel
NPI 1962578591
$19,806.56
in general payments reported to CMS, 2019-2025
38 companies · $8,051 in 2025
The $8,051 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $2,901 · 2020: $1,955 · 2021: $1,657 · 2022: $2,003 · 2023: $1,967 · 2024: $1,272 · 2025: $8,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,769 · Food and Beverage: $4,856 · Travel and Lodging: $495 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,769.00 |
| Food and Beverage | $4,855.99 |
| Travel and Lodging | $495.36 |
| Education | $170.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $6,908.94 | 2022-2025 | Optimizer, Optimizer |
| Astrazeneca Pharmaceuticals LP | $1,291.04 | 2019-2025 | Farxiga |
| Opsens INC. | $1,224.41 | 2019-2020 | |
| Amgen INC. | $1,202.85 | 2019-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $951.53 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $922.08 | 2021-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $724.40 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $675.90 | 2019-2024 | Lifevest |
| Chiesi USA, INC. | $566.12 | 2019-2025 | Kengreal, Cleviprex |
| Alnylam Pharmaceuticals INC. | $537.72 | 2024-2025 | Onpattro, Amvuttra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $507.96 | 2019-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $457.27 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $456.59 | 2019-2024 | Xarelto |
| Abbott Laboratories | $455.01 | 2019-2025 | Coroflow, Cardiomems, Merlin@Home |
| Biotronik INC. | $421.99 | 2019-2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $352.39 | 2019-2025 | |
| Abiomed | $322.12 | 2019-2025 | Impella |
| Medtronic, INC. | $256.91 | 2021-2025 | Cobalt Dr Mri Surescan, Micra, Linq II |
| Boston Scientific Corporation | $202.98 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Bodyguardian, S-Icd System Magnet |
| Philips North America LLC | $180.10 | 2020-2024 | (Ck4) Mcot |
| Shockwave Medical, INC | $178.50 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Actelion Pharmaceuticals US, INC. | $162.51 | 2023 | Opsumit, Uptravi |
| Cvrx, INC. | $155.51 | 2022-2023 | Barostim Neo System |
| Edwards Lifesciences Corporation | $141.80 | 2020-2025 | Inspiris Resilia Aortic Valve |
| Regeneron Healthcare Solutions, INC. | $103.09 | 2019 | |
| Atricure, INC. | $80.24 | 2022-2025 | Atriclip Laa Exclusion System |
| Kestra Medical Technology Services, INC. | $74.93 | 2022-2023 | Assure Wcd |
| Medtronic Vascular, INC. | $51.40 | 2019-2020 | |
| Elutia, INC. | $46.93 | 2020-2021 | |
| Preventice Services, LLC | $30.91 | 2020 | |
| Amarin Pharma, INC. | $29.37 | 2019-2020 | |
| Cardiovascular Systems INC. | $27.89 | 2022-2023 | Diamondback Coronary |
| Irhythm Technologies, INC. | $22.99 | 2024 | Zio Monitor, Zio Xt Patch |
| Lexicon Pharmaceuticals, INC. | $21.81 | 2023 | Inpefa |
| Novo Nordisk INC | $16.75 | 2024 | Wegovy |
| Portola Pharmaceuticals, LLC | $16.47 | 2019 | |
| Corcept Therapeutics | $14.59 | 2025 | Korlym |
| Kiniksa Pharmaceuticals, LTD. | $12.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$96.32 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Michel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.